Trinity Biotech plc (TRIB) recently provided an update on its continued development of its glucose biosensor technology. Earlier this year, the company was granted a European patent for a novel method that enhances the performance of its glucose biosensor. Recent testing of this patented process has confirmed its effectiveness in improving the performance of the sensor.Trinity Biotech intends to use this breakthrough process to stabilize and improve the functionality of its glucose biosensor in its next-gen ...